Navigation Links
CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
Date:11/7/2007

Relations

T: +32-2-559-9414

antje.witte@ucb-group.com

Mareike Mohr, Investor Relations

T: +32-2-559-9264

mareike.mohr@ucb-group.com

Notes to Editors:

RAPID Clinical Trials Program

The RAPID series of clinical trials were designed to establish the efficacy and tolerability of CIMZIA(R) (certolizumab pegol) in the treatment of rheumatoid arthritis. The RAPID clinical trial program is comprised of two large, international, multi-center placebo-controlled studies - RAPID 1 (027) and RAPID 2 (050).

In the year-long RAPID 1 trial, 982 patients were randomly allocated to receive one of three treatment regimens:

-- 393 patients received 400 mg formulation CIMZIA at the start of the

study and at weeks two and four, then 200 mg given every two weeks,

together with methotrexate;

-- 390 patients received 400 mg formulation CIMZIA every two weeks,

together with methotrexate;

-- 199 patients received placebo every two weeks, together with

methotrexate.

In all three arms of the study, the dose of methotrexate was 10 mg per week or greater. Co-primary endpoints for the study RAPID 1 were the ACR20 responder rate(a) at week 24 and the change from baseline in mTSS(b) at week 52.

Six and 12 month ACR responses for RAPID 1

CIMZIA(R) CIMZIA(R)

(certolizumab (certolizumab

pegol) pegol)

Placebo & MTX 200mg & MTX 400mg & MTX

Six months

ACR 20 13.6 58.8 60.8*

ACR 50 7.6 37.1* 39.9*

ACR 70 3.0 21.4* 20.6*

12 months

ACR 20 13.1 53.1* 54.9*

'/>"/>
SOURCE UCB
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
2. DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
3. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
4. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
5. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
6. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
7. Promising Phase 3 Trial Results Show Novel Biologic Therapy Ustekinumab (CNTO 1275) Significantly Improved Psoriasis
8. INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
9. New Data Published in Neurology Show Once-Daily Lamictal XR Significantly Reduced Partial Seizures in Patients with Epilepsy
10. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
11. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Dec. 18, 2014   Aratana Therapeutics, Inc ... company focused on the licensing, development and commercialization ... positive results from its pivotal field study of ... pain in dogs with osteoarthritis.  In the study, ... scores that were statistically significant compared to placebo ...
(Date:12/19/2014)... robust development with the growth pace keeping at 20%-30% in ... the size of China separating membrane ... to 16.3%. It is projected that China ... around 20% in the upcoming years and that the figure ... An integrated membrane industrial system has taken shape in ...
(Date:12/17/2014)... , Alemania, December 17, 2014 ... anterior, con un alto nivel de gasto en investigación ... fiscal 2013/14 (finalizado el 30 de septiembre de 2014) ... a 4.287 millones de euros (año anterior: 4.190 millones ... moneda desfavorables. Las ganancias (EBIT) crecieron un 14 por ...
Breaking Medicine Technology:Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 2Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 3ZEISS confirma su posición en un entorno difícil 2
... Texas , May 3 US ... today launched new flexible offerings that can be customized ... practices. Through these expanded offerings, physicians can join more ... of US Oncology to work together to realign ...
... May 3 MAQUET Cardiovascular LLC today ... of the new VASOSHIELD Pressure Controlling Syringe for use ... syringe limits internal "flushing" pressure and controls vessel distension ... in bypass surgery. Avoiding excessive pressure and limiting distension ...
Cached Medicine Technology:US Oncology Launches New Flexible Options for Community Oncologists to Join the United Network of US Oncology 2US Oncology Launches New Flexible Options for Community Oncologists to Join the United Network of US Oncology 3US Oncology Launches New Flexible Options for Community Oncologists to Join the United Network of US Oncology 4MAQUET Cardiovascular Introduces New VASOSHIELD Pressure Controlling Syringe to Help Preserve Graft Integrity for Coronary Artery Bypass Surgery Patients 2MAQUET Cardiovascular Introduces New VASOSHIELD Pressure Controlling Syringe to Help Preserve Graft Integrity for Coronary Artery Bypass Surgery Patients 3MAQUET Cardiovascular Introduces New VASOSHIELD Pressure Controlling Syringe to Help Preserve Graft Integrity for Coronary Artery Bypass Surgery Patients 4
(Date:12/20/2014)... 20, 2014 Dress company LunaDress has recently ... announced its Christmas Sale, offering big discounts on all of ... has an idea to own a perfect wedding gown. If ... wedding dress, then come to LunaDress. Many different wedding dress ... Visit our website now and enjoy the current special offer, ...
(Date:12/20/2014)... December 20, 2014 The print component ... with a distribution of approximately 160,000 copies and an ... nationally through a vast social media strategy and across ... To explore the digital version of the campaign, ... exclusive interview with the ladies of CTV’s The Social. ...
(Date:12/20/2014)... Recently, VogueQueen.com, a leading wedding dress wholesaler and retailer, ... for 2015. Great discounts are now offered on all ... get a discount, up to 80% off, when they ... 30, 2015. , VogueQueen.com has recently released its new ... promotion. Many customers worldwide like VogueQueen’s special designs which ...
(Date:12/20/2014)... Angeldress.co.uk, the distinguished wedding dress manufacturer and ... fans. The company has recently updated its official blog ... holiday season, Angeldress Blog has recommended some ... Angeldress.co.uk prides itself in offering a huge selection of ... the company’s outfits are very carefully selected based on ...
(Date:12/20/2014)... Atore, Inc, (San Francisco, CA CEO: Masashi ... focused portal on December 17th, 2014. , One ... US and Japan. , MERRY BIRTHDAY SITE : ... , MERRY BIRTHDAY MESSAGE is part of 5 future ... Features, Choose from thousands of stock photos to decorate ...
Breaking Medicine News(10 mins):Health News:2015 Collection of Wedding Dresses from LunaDress Online on Sale Now 2Health News:The ladies of The Social urge Canadian women to put themselves first over the holiday season and into the new year in Mediaplanet’s “Women’s Health” campaign 2Health News:VogueQueen Big Sale Online For The Coming 2015 2Health News:Trendy Professional Wedding Apparel Recommended by Angeldress Blog 2Health News:Atore, Inc. Releasing the First Birthday Portal 2
... Barcelona, Spain: The largest study in Europe ... after breast cancer has found that women from poorer backgrounds ... by more advanced cancer at diagnosis. Although other studies ... consulting their doctors at a later stage when their cancer ...
... available in Spanish . Barcelona, Spain: ... surviving breast cancer and delaying childbirth, it is important to ... consideration when deciding on treatment, the seventh European Breast Cancer ... Armstrong, from the Department of Medical Oncology, the Christie NHS ...
... and Oslo will be invited to take part in ... find out how influenza in pregnancy affects maternal health ... of vaccination during pregnancy. In October, November ... in Norway. Many young people and pregnant women became ...
... ... top honors in Security Information/Event Management Category. , ... (PRWEB) March 24, 2010 -- LogMatrix, ... solutions announced today that Info Security Products Guide, a leading publication of security-related ...
... U.S. expert says screening is best way to prevent breast ... women for breast cancer does not appear to increase overall ... increased survival rates may instead be due to controlling risk ... is not as good as we hoped years ago," said ...
... ... for managing and paying bills at FinovateSpring in San Francisco in May 2010. ... (PRWEB) March 24, ... service for managing and paying bills. Controlabill is an Australian based start-up founded ...
Cached Medicine News:Health News:Worse breast cancer outcomes for women from poorer backgrounds are not due to late diagnosis alone 2Health News:Worse breast cancer outcomes for women from poorer backgrounds are not due to late diagnosis alone 3Health News:Fertility issues in young women with breast cancer must be addressed 2Health News:Influenza in pregnancy -- new Norwegian study 2Health News:LogMatrix Wins Info Security Products Guide “2010 Global Product Excellence Customer Trust Award” 2Health News:LogMatrix Wins Info Security Products Guide “2010 Global Product Excellence Customer Trust Award” 3Health News:Mammograms May Not Boost Survival, Danish Study Suggests 2Health News:Mammograms May Not Boost Survival, Danish Study Suggests 3Health News:Global Financial Innovations Conference Chooses Australian Start Up, Controlabill 2
... need to add individual components for individual ... trauma indications. Made of an innovative composite ... fixators, only much lighter. This means it's ... more comfortable for the patient. ,Comes pre-assembled, ...
... osmolar ionic dimer. Each milliliter contains ... mg of ioxaglate sodium and 0.10 ... a stabilizer. The solution contains 3.48 ... and provides 32% (320 mg/mL) organically ...
... (iopamidol injection) is a safe and effective ... clinical experience since 1986. Worldwide, more ... been administered. Indicated for a wide ... flexibility by providing a wide range of ...
... is a formulation of iopamidol in ... oral administration or, where necessary, by ... improvement in the radiological exploration of ... contrast media. Thanks to its low ...
Medicine Products: